Six product families organize the catalog: discovery and translational research, diagnostics and clinical research, human ID and forensics, next-generation sequencing, instruments and automation, and informatics and data. Named test lines include QuantiFERON-TB Gold Plus, QuantiFERON Transplant, artus Viral Load, QIAstat-Dx for syndromic infectious disease panels, therascreen for solid tumors, and ipsogen for leukemia, alongside cervical cancer screening, maternal and fetal testing, and sexually transmitted infection testing. Preanalytical options extend to the PAXgene Urine Liquid Biopsy Set, described as the first integrated workflow for cell-free DNA analysis from urine, and to QIAwave extraction kits, which match standard kit performance using up to 63 percent less plastic. Experiment planning happens in GeneGlobe and the Workflow Configurator, and subsidiaries in 25 countries serve more than 500,000 customers, among them over 35 Nobel Prize winners. QIAGEN sums up its own standard in three words: Quality, Ingenuity and Accessibility.
QIAGEN
QIAGEN is a global leader in Sample to Insight solutions, providing advanced sample technologies for isolating nucleic acids and digital insight solutions for transforming raw biological data into valuable molecular conclusions. Serving molecular diagnostics, applied testing, and academic research markets, QIAGEN's assay technologies and bioinformatics platforms empower precision medicine and scientific breakthroughs worldwide.
